Epilepsiae

The project intends to develop an intelligent alarming system, transportable by the patient, measuring the brain dynamical activity, capable of predicting the seizures, allowing the patient to assess the risk of his actual situation and improving his safety The system is based on multi-signal information (EEG, ECG and others), intelligent data processing and wireless communications.

The project will develop knowledge (in data analysis), algorithms (of seizure prediction) and technologies (of data acquisition and wireless transmission) that integrated into an intelligent system will be an important step forward in economical affordable personal healthcare systems for neurological applications. A distributed European Epilepsy Database will also be built by the project, including all the available information about epileptic patients, allowing semantic mining based on multi-modal, multisignal and multidimensional data.

The Epilepsiae consortium consists of seven partners from 4 countries: 3 academic, 3 clinics, 1 industrial SME company, covering the whole value chain from theoretical conception to market products and final users.

For further information, please visit:
http://www.epilepsiae.eu

Project co-ordinator:
FACULDADE CIENCIAS E TECNOLOGIA DA UNIVERSIDADE DE COIMBRA (Portugal)

Partners:

  • ALBERT-LUDWIGS-UNIVERSITAET FREIBURG (Germany)
  • MICROMED S.P.A. (Italy)
  • UNIVERSITAETSKLINIKUM FREIBURG (Germany)
  • CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (France)
  • HOSPITAIS DA UNIVERSIDADE DE COIMBRA (Portugal)

Timetable: from 01/2008 – to 12/2010

Total cost: €4.153.125

EC funding: €2.919.805

Programme Acronym: FP7-ICT

Subprogramme Area: Advanced ICT for risk assessment and patient safety

Contract type: Collaborative project (generic)

Related news article:

Most Popular Now

Making Cancer Vaccines More Personal

In a new study, University of Arizona researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumor proteins, or neoantigens, that...